Director Shareholding

GlaxoSmithKline PLC 16 July 2004 Director's Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 12 July 2004 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 15 July 2004 that following re-investment of the cash dividend paid to the shareholders on 1 July 2004, 1,287 Ordinary shares in the Company had been purchased for participants in the SmithKline Beecham Bonus Investment Plan at a price of £10.82 and that 1,334 Ordinary Shares had been transferred to a participant in the SmithKline Beecham Bonus Investment Plan. The Trust also notified the Company on 15 July that following reinvestment of the cash dividend paid to shareholders on 1 July 2004, 9,075 Ordinary shares in the Company had been purchased for participants in the GlaxoSmithKline Annual Investment Plan at a price of £10.82. The Trust also notified the Company on 15 July that 1,651 Ordinary Shares had been transferred to participants of the Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. One of the Company's directors, John Coombe is therefore interested in the shares held in the fund from time to time in the same way as other non US employees or former employees of GlaxoSmithKline plc and its subsidiaries. S M Bicknell Company Secretary 16 July 2004 This information is provided by RNS The company news service from the London Stock Exchange MMMBBPI

Companies

GSK (GSK)
UK 100

Latest directors dealings